Literature DB >> 27367889

Effect of Anti-IL-13 Treatment on Airway Dimensions in Severe Asthma.

Christopher E Brightling1, Lars H Nordenmark2, Meena Jain3, Edward Piper4, Dewei She5, Martin Braddock4, Gene Colice6, Göran Tornling2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27367889     DOI： 10.1164/rccm.201511-2224LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

1.  IL-13 and FOXO3 genes polymorphisms regulate IgE levels in asthmatic patients.

Authors:  Amer Imraish; Tuqa Abu-Thiab; Malek Zihlif
Journal:  Biomed Rep       Date:  2021-04-13

Review 2.  Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma.

Authors:  Andrew Gallagher; Michaela Edwards; Parameswaran Nair; Stewart Drew; Aashish Vyas; Rashmi Sharma; Paul A Marsden; Ran Wang; David Jw Evans
Journal:  Cochrane Database Syst Rev       Date:  2021-10-19

3.  Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.

Authors:  Wanda Phipatanakul; David T Mauger; Ronald L Sorkness; Jonathan M Gaffin; Fernando Holguin; Prescott G Woodruff; Ngoc P Ly; Leonard B Bacharier; Nirav R Bhakta; Wendy C Moore; Eugene R Bleecker; Annette T Hastie; Deborah A Meyers; Mario Castro; John V Fahy; Anne M Fitzpatrick; Benjamin M Gaston; Nizar N Jarjour; Bruce D Levy; Stephen P Peters; W Gerald Teague; Merritt Fajt; Sally E Wenzel; Serpil C Erzurum; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

4.  Association between IL-13 +1923C/T polymorphism and asthma risk: a meta-analysis based on 26 case-control studies.

Authors:  Yueli Xu; Junjuan Li; Zhaolei Ding; Juan Li; Bin Li; Zhengang Yu; Wei Tan
Journal:  Biosci Rep       Date:  2017-01-27       Impact factor: 3.840
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.